Feature Image

MJNA’s 3Q Financial Results Featured in Various Media Outlets

The announcement of MJNA’s record-breaking Q3 revenue numbers were covered by at least eight investment and financial media outlets.

Several media outlets ran articles spotlighting Medical Marijuana, Inc.’s financial results for the third quarter ending September 30, 2017.

MJNA released its Q3 financial numbers earlier this month, revealing a 255% quarter-over-quarter increase in gross revenue. The Company’s gross revenue surged from $2,188,671 in Q3 2016 to $7,783,297 in Q3 2017.

Additionally, MJNA reported a total gross profit increase from $1,266,488 in Q3 2016 to $5,034,464 in Q3 2017, a 297% quarter-over-quarter jump. The company also saw a year-over-year increase in year-to-date gross revenue, from $5,450,080 in 2016 to $17,098,785 in 2017.

National financial and investing outlets covered the release of MJNA’s financial results. In CFN Media Group’s coverage of the announcement, the leading cannabis media network referred to MJNA as “a compelling opportunity in the cannabis space.” After citing the company’s strong growth during the third quarter, CFN Media Group touted MJNA’s “diversified operations across many geographies and subsets of the cannabis industry.”

The CFN Media Group article also highlighted the achievements of MJNA’s investment portfolio, spotlighting the company’s total equity of $334,136,047 as of last quarter.

The piece showcased the announcement of MJNA investment company AXIM® Biotechnologies clinical study agreement with the University of British Columbia with its CanChew Plus® CBD chewing gum for drug-induced psychosis in adults. It also noted MJNA investment company Kannalife™ Sciences’s presentation of scientific data from its clinical trials at this year’s Annual ICRS Symposium on the Cannabinoids.

In conclusion, the media outlet suggested MJNA is a “unique opportunity,” as the North American cannabidiol (CBD) market expected to surpass $1 billion by 2020.

Further Media Coverage

Coverage of MJNA’s Q3 financial results can also be found at the following media sources:

Learn More about MJNA

Medical Marijuana, Inc. is the first-ever publicly traded cannabis company in the United States. You can learn more about MJNA’s achievements this year so far HERE, or read through the company’s full Q3 financial results HERE.

Keep up with the latest updates regarding Medical Marijuana, Inc. and its portfolio of companies by regularly visiting our company news page.